On January 29, 2021, the Institute for the Hospital Remuneration System (InEK) has published the List of the requests for innovation funding (NUB) that were submitted by the hospitals in 2020.
Out of 818 submitted technologies, 213 (26%) received the positive status 1, which means that the suggested procedure or medical device met the NUB criteria, so now the hospitals can negotiate the innovation funding for these technologies with the sickness funds.
Furthermore, 36 (4%) technologies received differentiated status, which means that status 1 can be granted only under certain conditions.
The full list of medical technologies (n=78, excluding pharmaceuticals), which obtained status 1, is provided below. The technologies are listed according to the number of received applications for funding. The technologies with differentiated status were not included in the list.
- Insertion of coated (covered) stents with a bioactive surface for peripheral vessels
- Covered endoprosthesis with a bioactive surface for dialysis shunt revision
- Ascites treatment using a fully implantable pump
- External stabilization scaffold for anastomosis of an AV shunt as part of shunt surgery
- Endovascular system of an internal AV shunt using magnetically guided radiofrequency energy
- Hemodynamically effective implant for the endovascular treatment of intracranial aneurysms and brain-supplying neck vessels
- Intra-aneurysmal hemodynamically effective implant for endovascular treatment of intracranial aneurysms
- Flow-reducing wire mesh in the coronary sinus
- Removable, ultra-soft microcoils for intracranial therapy of vascular malformations and aneurysms
- The intra-aortic catheter with paracorporeal membrane pump for circulatory support of the left ventricle
- Gastric pacemaker implantation
- Extra-corporeal neurostimulation system for the peripheral nervous system
- Percutaneous transluminal insertion of an atrial septal implant for the treatment of heart failure
- Transfer of virus-specific donor immune cells after allogeneic stem cell transplantation
- Therapy of scoliosis using magnetically controlled rods
- Focal photodynamic therapy with padeliporfin for the treatment of localized prostate cancer
- Transcatheter implantation of an interatrial shunt device for the treatment of heart failure
- Endovascular implantation of an extra-corporeal centrifugal pump for circulatory support
- Mesenchymal stem cells
- Transapical mitral valve reconstruction by implantation of neochordae (PTFE)
- Vertebral bodies growth modulation technique
- Temporomandibular joint endoprosthesis (total replacement)
- Endovascular mitral valve annuloplasty with an annuloplasty band
- Administration of CAR-T cells for the treatment of hematological diseases
- Minimally invasive LV-reconstruction with a myocardial anchoring system
- Intra-aortal balloon occlusion with extra-corporeal circulation
- Catheter-based implant for the treatment of left ventricular cardiac motility disorders
- Insertion of coated (covered) stents with a bioactive surface for peripheral and other vessels
- Wireless left ventricular cardiac pacing system for cardiac resynchronization therapy
- Implantation of growing heart valves
- Therapy of scoliosis using a screw and rod system that grows with the patient
- Endo-Exo-Prostheses
- Replacement of the pulmonary trunk or parts of the aorta with an acellular allograft
- Percutaneous transluminal implantation of an interatrial shunt for the treatment of heart failure with preserved or reduced left ventricular ejection fraction
- Forming of a sleeve stomach (sleeve resection), endoscopic
- Endovascular forming of a peripheral AV fistula via direct current
- Radioligand therapy with Actinium-225-PSMA-ligands
- Insertion of coated (covered) stents with a bioactive surface for intraabdominal, cranial, or peripheral vessels
- Implant for direct acoustic stimulation of the cochlea (DACI)
- Apicoaortal valve-carrying conduit
- Insertion of coated (covered) stents with a bioactive surface for visceral and supra-aortic vessels
- Acoustic neurinoma surgery with simultaneous cochlear implantation
- Endovascular implantation of a stent-graft with valve element for tricuspid valve regurgitation
- Fetoscopic drainage therapy
- Radioimmunotherapy with anti-CD19, anti-CD45, and anti-CD66 antibodies
- Epiretinal retinal prosthesis
- Endovascular mitral valve annuloplasty with seam anchoring
- Fetoscopic tracheal balloon occlusion in diaphragmatic hernia and premature bladder rupture
- Intracavitary radiotherapy with Iodine-125
- Lutetium-177- or Yttrium-90-pentixafor therapy
- Pulmonary arterial banding, telemetrically adjustable
- Closure of umbilical cord and intrafetal vessels by percutaneous ultrasound-controlled radiofrequency ablation or fetoscopic laser ablation
- Boston keratoprosthesis
- Fetoscopic opening of narrowed semilunar valves and the foramen ovale
- Auditory brainstem implant
- Fetoscopic therapy of fetal supraventricular tachycardia and larynx or trachea occlusion
- Thyroplasty implant with the possibility of postoperative adjustment of vocal fold position
- Keratoprosthesis, biologically coated
- Growth endoprosthesis
- Continuous amniotic infusion using the subcutaneously implanted port system
- Radionuclide therapy with lutetium-177-bisphosphonate in bone metastases of prostate cancer
- Uterine shield closure after fetoscopic interventions
- Allogenic hepatocytes transplantation
- Artificial larynx after total laryngectomy
- Percutaneous-transthoracic tricuspid valve replacement
- Uterus transplantation
- Auditory middle brain implant
- Percutaneous caval valve stent placement
- Radionuclide therapy with Iodine-131-azetidinylamide in metastatic adrenal carcinoma
- Subretinal active implant
- Autologous matrix-induced hepatocytes transplantation
- Treatment of fatal epidermolysis bullosa junctionalis (M. Herlitz type) by transplantation of haploidentical bone marrow and skin of the same donor
- Treatment of children with rhabdomyosarcomas of the bladder/prostate/rectum / perineal region with organ-preserving surgery and interstitial HDR brachytherapy
- Joint transplants with thin-layered, fresh, living, allogeneic cartilage or bone material
- Gene therapy with autologous CD34+ enriched cells with ARSAGs for the treatment of metachromatic leukodystrophy
- Combined renal and stem cell transplantation (living donation)
- Radionuclide therapy with Iodine-131-metomidate
- Complete face transplantation
Four new technologies (percutaneous transluminal implantation of an interatrial shunt for the treatment of heart failure with preserved or reduced left ventricular ejection fraction, endovascular implantation of a stent-graft with valve element for tricuspid valve regurgitation, thyroplasty implant with the possibility of postoperative adjustment of vocal fold position, gene therapy with autologous CD34+ enriched cells with ARSAGs for the treatment of metachromatic leukodystrophy) received status 1 in comparison with the 2020 list.
The full details in German can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.